Modulators of tumor responsiveness to radioimmunotherapy.
SRI International, Life Sciences Division, Menlo Park, Calif.
J K
JK
McGann
V K
VK
Langmuir
R M
RM
Sutherland
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000532:radiotherapy*
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal